| Company: | AtriCure, Inc. |
| Ticker Symbol: | NASD: ATRC |
| Class Period: | August 4, 2005 to February 16, 2006 |
| Date Filed: | Dec-11-06 |
| Lead Plaintiff Deadline: | Feb-09-07 |
| Court: | Southern District, NY |
| Allegations: |
A class action lawsuit was filed in the United States District Court for the Southern District of New York on behalf of all common stock purchasers of AtriCure, Inc. (Nasdaq: ATRC - News; "AtriCure" or the "Company") pursuant and/or traceable to the Company's initial public offering on or about August 4, 2005 through February 16, 2006, inclusive (the "Class Period").
The Complaint charges AtriCure and certain of its officers and directors with violations of the Securities Act of 1933. More specifically, the Complaint alleges that AtriCure's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about August 4, 2005 failed to disclose that the Cleveland Clinic, where a significant portion of procedures with the Company's products were being performed, was an investor in the Company and that doctors from the Cleveland Clinic had been paid consultants to the Company.
On February 16, 2006, AtriCure announced financial results for the fourth quarter of 2005 and the fiscal year ended December 31, 2005. Among other things, the Company reported that it was experiencing a "negative impact" on its business due to the revelations concerning the Cleveland Clinic. In response to this announcement, the price of AtriCure common stock dropped from $10.36 per share to $8.04 per share on extremely heavy trading volume.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
The Complaint charges AtriCure and certain of its officers and directors with violations of the Securities Act of 1933. More specifically, the Complaint alleges that AtriCure's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about August 4, 2005 failed to disclose that the Cleveland Clinic, where a significant portion of procedures with the Company's products were being performed, was an investor in the Company and that doctors from the Cleveland Clinic had been paid consultants to the Company.
On February 16, 2006, AtriCure announced financial results for the fourth quarter of 2005 and the fiscal year ended December 31, 2005. Among other things, the Company reported that it was experiencing a "negative impact" on its business due to the revelations concerning the Cleveland Clinic. In response to this announcement, the price of AtriCure common stock dropped from $10.36 per share to $8.04 per share on extremely heavy trading volume.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
